JP Morgan analyst Lisa Gill downgrades Bright Health Gr (NYSE:BHG) from Neutral to Underweight.
Natuzzi Q3 Sales $81.525M (€74.9M)
THIRD QUARTER 2023 HIGHLIGHTS3Q 2023 INVOICED SALES AMOUNTED TO €74.9 MILLION, REFLECTING A DECREASE OF 35.8% COMPARED TO 3Q 2022. THIS IS EQUIVALENT TO A DECREASE OF 15.2% COMPARED TO THE NORMALIZED SALES OF 3Q 2022,